ADIPOQ and metabolic syndrome: Although there are reports in which adiponectin has not been shown to be a useful biomarker for monitoring changes observed in MetS [16,17], evidence exists for postulating this cytokine as a biomarker of MetS and T2D in obese children and adolescents [13,14,34,35].